Glenmark announced a consumer level recall of 114 lots of potassium chloride extended-release capsules because they may not dissolve correctly which may lead to hyperkalemia.
Classification Type: Class 1 Recall
Optum Clinical Services has sent a drug recall notification to potentially impacted members and providers. Below are the notification details.
|
Product
|
Potassium chloride extended-release capsules
|
|
Manufacturer
|
Glenmark
|
|
Recall Identification date
|
06/25/2024
|
|
Affected NDCs
|
68462035701, 68462035705
|
|
Look back period
|
2/25/24 - 6/25/24
|
|
Target population for clinical mailing
|
All
|
|
Messaging type
|
Mailing: Members; Direct Message/Fax; Providers
|
|
Data release
|
SS00005114
|
|
Fulfillment due date for NCQA compliance
|
On or before: 07/15/2024
|
|
WHA impacted members
|
19 members
|
|
Date letters were mailed out
|
7/10/2024
|
Last review date: August 28, 2024